<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE article
  PUBLIC "-//NLM//DTD Journal Publishing DTD v2.3 20070202//EN" "journalpublishing.dtd">
<article xmlns:xlink="http://www.w3.org/1999/xlink" article-type="research-article" xml:lang="en">
<front>
<journal-meta>
<journal-id journal-id-type="publisher-id">TAW</journal-id>
<journal-id journal-id-type="hwp">sptaw</journal-id>
<journal-title>Therapeutic Advances in Drug Safety</journal-title>
<issn pub-type="ppub">2042-0986</issn>
<issn pub-type="epub">2042-0994</issn>
<publisher>
<publisher-name>SAGE Publications</publisher-name>
<publisher-loc>Sage UK: London, England</publisher-loc>
</publisher>
</journal-meta>
<article-meta>
<article-id pub-id-type="doi">10.1177/2042098613477125</article-id>
<article-id pub-id-type="publisher-id">10.1177_2042098613477125</article-id>
<article-categories>
<subj-group subj-group-type="heading">
<subject>Reviews</subject>
</subj-group>
</article-categories>
<title-group>
<article-title>Systems that prevent unwanted represcription of drugs withdrawn because of adverse drug events: a systematic review</article-title>
</title-group>
<contrib-group>
<contrib contrib-type="author" corresp="yes">
<name><surname>van der Linden</surname><given-names>Carolien M.J.</given-names></name>
<aff id="aff1-2042098613477125">Catharina Hospital, PO Box 1350, 5602 ZA, Eindhoven, the Netherlands</aff>
</contrib>
<contrib contrib-type="author">
<name><surname>Jansen</surname><given-names>Paul A.F.</given-names></name>
<aff id="aff2-2042098613477125">Department of Geriatrics, University Medical Centre Utrecht, and EPHOR Expertise Centre Pharmacotherapy in Old Persons, the Netherlands</aff>
</contrib>
<contrib contrib-type="author">
<name><surname>Grouls</surname><given-names>René J.E.</given-names></name>
<aff id="aff3-2042098613477125">Catharina Hospital Eindhoven, the Netherlands</aff>
</contrib>
<contrib contrib-type="author">
<name><surname>van Marum</surname><given-names>Rob J.</given-names></name>
<aff id="aff4-2042098613477125">Jeroen Bosch Hospital, ’s-Hertogenbosch, the Netherlands</aff>
</contrib>
<contrib contrib-type="author">
<name><surname>Verberne</surname><given-names>Marianne A.J.W.</given-names></name>
</contrib>
<contrib contrib-type="author">
<name><surname>Aussems</surname><given-names>Lieke M.A.</given-names></name>
<aff id="aff5-2042098613477125">Medical Student, Maastricht University, the Netherlands</aff>
</contrib>
<contrib contrib-type="author">
<name><surname>Egberts</surname><given-names>Toine C.G.</given-names></name>
<aff id="aff6-2042098613477125">Hospital Pharmacist, University Medical Centre Utrecht and Utrecht Institute for Pharmaceutical Sciences Utrecht, the Netherlands</aff>
</contrib>
<contrib contrib-type="author">
<name><surname>Korsten</surname><given-names>Erik H.M.</given-names></name>
<aff id="aff7-2042098613477125">Anesthesiologist, Catharina Hospital Eindhoven and Eindhoven University of Technology, the Netherlands</aff>
</contrib>
</contrib-group>
<author-notes>
<corresp id="corresp1-2042098613477125"><email>carolien.vd.linden@catharinaziekenhuis.nl</email></corresp>
</author-notes>
<pub-date pub-type="epub-ppub">
<month>4</month>
<year>2013</year>
</pub-date>
<volume>4</volume>
<issue>2</issue>
<fpage>73</fpage>
<lpage>90</lpage>
<permissions>
<copyright-statement>© The Author(s), 2013</copyright-statement>
<copyright-year>2013</copyright-year>
<copyright-holder content-type="sage">SAGE Publications</copyright-holder>
</permissions>
<abstract>
<p>Represcription of medication that was withdrawn after the occurrence of an adverse drug event (including allergy), is a recognized medication safety issue on a patient level. We performed a systematic review to identify systems (electronic and nonelectronic) that can prevent the represcription of drugs withdrawn because of an adverse drug event and the effects of these systems. The review was performed using PRISMA and Cochrane guidelines. PubMed and Embase were searched for articles describing systems that can prevent represcription of drugs that had been withdrawn for causing an adverse drug event. Information on the characteristics of the studies, systems, and if present results achieved with such systems, was extracted. The results showed that of 6793 articles screened, 137 full-text articles were assessed for eligibility. A total of 45 studies describing 33 systems (28 electronic) were included. The five nonelectronic systems used allergy bracelets or allergy labels on hospital medical records or on drug orders. Systems differed in the way adverse drug events were documented and how users were alerted to drug represcription. Most systems functioned within a specific healthcare setting. Of 12 studies that compared pre- and post-intervention periods or wards with and without intervention, 7 showed a reduction in represcription after adverse drug event. In conclusion, several systems have been developed that can prevent the represcription of drugs that elicited an adverse drug event, but the evidence that these systems are effective is limited.</p>
</abstract>
<kwd-group>
<kwd>adverse drug event</kwd>
<kwd>allergy</kwd>
<kwd>computerized physician order entry</kwd>
<kwd>clinical decision support</kwd>
</kwd-group>
</article-meta>
</front>
<body>
<sec id="section1-2042098613477125" sec-type="intro">
<title>Introduction</title>
<p>While medications usually improve patients’ quality and/or duration of life, they can also cause considerable harm, especially if prescribing clinicians fail to take relevant patient characteristics, such as known allergies, into consideration [<xref ref-type="bibr" rid="bibr27-2042098613477125">Kuperman <italic>et al</italic>. 2007</xref>]. In the Institute of Medicine’s report ‘<italic>To Err is Human</italic>’ from 1999, the death rate associated with medication errors was estimated at 7000 per year in the United States [<xref ref-type="bibr" rid="bibr26-2042098613477125">Kohn <italic>et al</italic>. 1999</xref>]. A subsequent report published in 2006 estimated that in the United States between 380,000 and 450,000 preventable adverse drug events (ADEs) occur annually in a hospital setting, at a cost of US$3.5 billion [<xref ref-type="bibr" rid="bibr2-2042098613477125">Aspden <italic>et al</italic>. 2006</xref>]. An ADE is defined as: ‘an injury resulting from medical intervention related to a drug’ [<xref ref-type="bibr" rid="bibr3-2042098613477125">Bates <italic>et al</italic>. 1995</xref>]. In a previous study, our group showed that ADEs that occurred and were documented during hospitalization and which required withdrawal of the causative drug were poorly communicated to general practitioners (GPs) and not at all to pharmacists, and that only 22% of the ADEs mentioned in discharge letters were incorporated into GP patient files. The rate of represcription of medication withdrawn during hospitalization because of an ADE was 27% in the first 6 months after discharge [<xref ref-type="bibr" rid="bibr49-2042098613477125">Van der Linden <italic>et al</italic>. 2006</xref>]. Poor documentation and communication probably contributed to this high rate of represcription. One condition, amongst others, that needs to be met to prevent prescription of medication to which patients earlier experienced an allergic reaction or another ADE, is that ADEs (including allergies) are well documented. In a study of 400 hospitalized patients, we found that the reasons for medication discontinuation were not reported in as many as 40% of the cases of medication discontinuation [<xref ref-type="bibr" rid="bibr50-2042098613477125">Van der Linden <italic>et al</italic>. 2010</xref>]. Khalil and colleagues found in their study that details of allergy were accurately reported in only 3 of 521 patients (0.6%), and that written records of ADEs were ineffective because insufficient information was recorded or because handwriting was illegible [<xref ref-type="bibr" rid="bibr24-2042098613477125">Khalil <italic>et al</italic>. 2011</xref>]. Information technology consisting of computerized physician order entry (CPOE) and clinical decision support (CDS) has the potential to address the problem of unwanted represcription of drugs earlier withdrawn because of an ADE. We performed a systematic review to identify systems (electronic and nonelectronic) that may prevent the represcription of drugs that caused ADEs at a patient level, and the effectiveness of these systems.</p>
</sec>
<sec id="section2-2042098613477125" sec-type="methods">
<title>Methods</title>
<p>This review was performed using the PRISMA guidelines for systematic reviews and meta-analysis [<xref ref-type="bibr" rid="bibr38-2042098613477125">Moher <italic>et al</italic>. 2009</xref>] and the Cochrane guidelines (see <ext-link ext-link-type="uri" xlink:href="http://www.cochrane-handbook.org/">http://www.cochrane-handbook.org/</ext-link>) where applicable.</p>
<sec id="section3-2042098613477125">
<title>Data sources and search strategy</title>
<p>Titles and abstracts in the PubMed and Embase databases were searched from inception to November 2011 using the terms ‘drug’ and ‘event’, ‘allergy’ or ‘hypersensitivity’ combined with ‘systems’, ‘surveillance’ or ‘alerts’, and synonyms. No limits were used in the searches. The search syntax used is shown in <xref ref-type="fig" rid="fig1-2042098613477125">Figure 1</xref>.</p>
<fig id="fig1-2042098613477125" position="float">
<label>Figure 1.</label>
<caption>
<p>Search syntax in PubMed and Embase.</p>
</caption>
<graphic xlink:href="10.1177_2042098613477125-fig1.tif"/>
</fig>
</sec>
<sec id="section4-2042098613477125">
<title>Study selection and eligibility</title>
<p>Duplicate articles were excluded and the title and abstract of remaining articles were screened by one reviewer (MV) and confirmed by another reviewer (CvdL) using the following exclusion criteria: (a) language other than English, German, French or Dutch; (b) animal studies or nonhuman studies; (c) study describing systems that do not function at the patient level; (d) study not concerning ADEs; (e) study describing a system not related to prevention of represcription; and (f) review articles. Criterion (c) means that the systems should be able to prevent prescription of a drug to a patient, when this drug was earlier withdrawn because of an ADE in this same patient. So, systems only enhancing reporting or documenting ADEs in a database were excluded. If the title and abstract were not sufficiently conclusive, full-text articles were retrieved. All relevant full-text articles were then screened by LA (confirmed by CvdL) using the same exclusion criteria. References of included articles were screened for relevant articles.</p>
</sec>
<sec id="section5-2042098613477125">
<title>Data extraction</title>
<p>One reviewer (LA) extracted information on the characteristics of the study (design, setting, population and country) and of the systems studied (electronic or nonelectronic, custom-designed or commercial), which was confirmed by CvdL. We also retrieved information about how ADEs were documented (by whom, when, voluntary or obligatory, automatic detection present or absent), how users were alerted to potential represcription of a discontinued drug (trigger, receiver and possible actions after the alert) and to whom information on the ADEs was available. If present, data on results on represcription after the occurrence of an ADE were also extracted.</p>
</sec>
<sec id="section6-2042098613477125">
<title>Data synthesis</title>
<p>Data were synthesized using narrative and tabular methods. As eligible studies were expected to differ substantially in terms of patient population, intervention and measurements methods, pooling of data was considered inappropriate. Results were judged as beneficial if a statistically significant (<italic>p</italic> &lt; 0.05) decrease in represcriptions after ADE was reported.</p>
</sec>
</sec>
<sec id="section7-2042098613477125" sec-type="results">
<title>Results</title>
<p>A total of 9903 articles were identified in the initial search. After elimination of duplicate studies, 6793 articles were screened for exclusion criteria (see <xref ref-type="fig" rid="fig2-2042098613477125">Figure 2</xref>), leaving 137 full-text articles that were assessed for eligibility. Of these 137 articles, 96 articles were excluded, mainly because these studies describe systems that do not prevent represcription of drugs withdrawn because of an ADE. A total of 41 articles were included; an additional 4 were included after screening of the reference lists of the included articles.</p>
<fig id="fig2-2042098613477125" position="float">
<label>Figure 2.</label>
<caption>
<p>Search results with reasons for exclusion.</p>
</caption>
<graphic xlink:href="10.1177_2042098613477125-fig2.tif"/>
</fig>
<sec id="section8-2042098613477125">
<title>Characteristics of the studies</title>
<p>The characteristics of the studies are shown in <xref ref-type="table" rid="table1-2042098613477125">Table 1</xref>.</p>
<table-wrap id="table1-2042098613477125" position="float">
<label>Table 1.</label>
<caption>
<p>Characteristics of included studies.</p>
</caption>
<graphic alternate-form-of="table1-2042098613477125" xlink:href="10.1177_2042098613477125-table1.tif"/>
<table>
<colgroup>
<col align="left"/>
<col align="char" char="."/>
</colgroup>
<thead>
<tr>
<th align="left">Characteristic</th>
<th align="left">Number (%) of studies</th>
</tr>
</thead>
<tbody>
<tr>
<td colspan="2">Year of publication</td>
</tr>
<tr>
<td> Before 1990</td>
<td>4 (9%)</td>
</tr>
<tr>
<td> 1990–2000</td>
<td>12 (27%)</td>
</tr>
<tr>
<td> After 2000</td>
<td>29 (64%)</td>
</tr>
<tr>
<td colspan="2">Geographic location</td>
</tr>
<tr>
<td> USA</td>
<td>29 (64%)</td>
</tr>
<tr>
<td> UK</td>
<td>5 (11%)</td>
</tr>
<tr>
<td> other in Europe</td>
<td>3 (7%)</td>
</tr>
<tr>
<td> Canada</td>
<td>3 (7%)</td>
</tr>
<tr>
<td> Asia</td>
<td>3 (7%)</td>
</tr>
<tr>
<td>Australia</td>
<td>1 (2%)</td>
</tr>
<tr>
<td> Israel</td>
<td>1 (2%)</td>
</tr>
<tr>
<td colspan="2">Study design</td>
</tr>
<tr>
<td> Pre-/post-intervention</td>
<td>16 (36%)</td>
</tr>
<tr>
<td> Descriptive</td>
<td>13 (29%)</td>
</tr>
<tr>
<td> Retrospective</td>
<td>9 (20%)</td>
</tr>
<tr>
<td> Interrupted time series</td>
<td>2 (4%)</td>
</tr>
<tr>
<td> Cohort studies</td>
<td>2 (4%)</td>
</tr>
<tr>
<td> Trend analysis</td>
<td>1 (2%)</td>
</tr>
<tr>
<td> User interviews</td>
<td>1 (2%)</td>
</tr>
<tr>
<td> Randomized controlled trial</td>
<td>1 (2%)</td>
</tr>
<tr>
<td colspan="2">Age of studied population</td>
</tr>
<tr>
<td> Not reported</td>
<td>30 (67%)</td>
</tr>
<tr>
<td> Adults</td>
<td>12 (27%)</td>
</tr>
<tr>
<td> Children</td>
<td>3 (7%)</td>
</tr>
</tbody>
</table>
</table-wrap>
<p>Most studies (64%) were published after the year 2000. The studies concerning electronic systems were published between 1976 and 2011, those concerning nonelectronic systems between 1967 and 2007. Of the 45 studies, 16 had a pre-/post-intervention design, 13 were descriptive studies, 9 were retrospective studies, 2 were cohort-studies, 2 had a time-series design (interrupted or prospective), 1 was a trend analysis, 1 performed user interviews and 1 was a randomized controlled trial. Most studies were performed in the United States (<italic>n</italic> = 29, 64%), and the majority (<italic>n</italic> = 30, 67%) did not report patient age; 12 studies (27%) involved adults and 3 (7%) children.</p>
</sec>
<sec id="section9-2042098613477125">
<title>Characteristics of the systems</title>
<p>The 45 articles described 33 different systems, 28 (85%) of which were electronic.</p>
<sec id="section10-2042098613477125">
<title>Commercially available or custom designed</title>
<p>Nine of the electronic systems (32%) were commercially available and 18 were custom designed; one study did not report whether a commercial or custom-designed system was used. Eight studies investigated the Brigham Integrated Computing System (BICS) and five the Health Evaluation through Logical Processing (HELP) system. The characteristics of the studies and systems are shown in <xref ref-type="table" rid="table2-2042098613477125">Table 2</xref> (electronic systems) and <xref ref-type="table" rid="table3-2042098613477125">Table 3</xref> (nonelectronic systems).</p>
<table-wrap id="table2-2042098613477125" position="float">
<label>Table 2.</label>
<caption>
<p>Characteristics of studies and systems: electronic.</p>
</caption>
<graphic alternate-form-of="table2-2042098613477125" xlink:href="10.1177_2042098613477125-table2.tif"/>
<table>
<colgroup>
<col align="left"/>
<col align="left"/>
<col align="left"/>
<col align="left"/>
<col align="left"/>
<col align="left"/>
<col align="left"/>
<col align="left"/>
<col align="left"/>
<col align="left"/>
<col align="left"/>
<col align="left"/>
<col align="left"/>
<col align="left"/>
<col align="left"/>
<col align="left"/>
<col align="left"/>
<col align="left"/>
</colgroup>
<thead>
<tr>
<th align="left">System name</th>
<th align="left" colspan="9">Characteristics of the system<hr/></th>
<th align="left" colspan="6">Characteristics of the study<hr/></th>
<th align="left" rowspan="3">Results<break/>On represcription after the occurrence of an ADE</th>
<th align="left" rowspan="3">Reference</th>
</tr>
<tr>
<th/>
<th align="left">C/H<xref ref-type="table-fn" rid="table-fn3-2042098613477125">*</xref></th>
<th align="left" colspan="4">Documentation of the ADE<hr/></th>
<th align="left" colspan="3">Alert in case of represcription<hr/></th>
<th align="left">Availability ADE information</th>
<th align="left">Country</th>
<th align="left">Design</th>
<th align="left">Setting</th>
<th align="left" colspan="3">Population<hr/></th>
</tr>
<tr>
<th/>
<th/>
<th align="left">By whom</th>
<th align="left">When</th>
<th align="left">O/V<xref ref-type="table-fn" rid="table-fn5-2042098613477125">^</xref></th>
<th align="left">Automatic detection<xref ref-type="table-fn" rid="table-fn4-2042098613477125">**</xref></th>
<th align="left">Trigger<xref ref-type="table-fn" rid="table-fn6-2042098613477125">^^</xref></th>
<th align="left">Receiver <xref ref-type="table-fn" rid="table-fn7-2042098613477125">#</xref></th>
<th align="left">Action</th>
<th/>
<th/>
<th/>
<th/>
<th align="left"><italic>N</italic> = Baseline/intervention <xref ref-type="table-fn" rid="table-fn8-2042098613477125"># #</xref></th>
<th align="left">Mean age</th>
<th align="left">Gender<break/>%F</th>
</tr>
</thead>
<tbody>
<tr>
<td>BICS (Brigham Integrated Computing System)</td>
<td>H</td>
<td>Physician</td>
<td>At admission</td>
<td>O</td>
<td>√<break/>lab results, antidotes</td>
<td>A<break/>CA<break/>RA</td>
<td>Phy</td>
<td>Stop order or override alert (+reason)</td>
<td>Inside hospital</td>
<td>USA</td>
<td>1: Retrospective record analysis<break/>2-5: Descriptive<break/>6: Trend analysis<break/>7: Retrospective Time series<break/>8: Pre-/post-intervention</td>
<td>720-Bed academic tertiary-care hospital, part of Partners HealthCare System</td>
<td>1: 1150 patients<break/>2-6: NR<break/>7: 10,070/14,352 orders<break/>8: 2,491/4220 admissions</td>
<td>1: 56<break/>2-7: NR<break/>8: 52.5/53.2</td>
<td>1: 68<break/>2-7: NR<break/>8: 50.9/54.3</td>
<td>1-6: No results<break/>7: 10 ‘known allergy errors’ in baseline period, 1 in intervention period, <italic>p</italic> &lt; 0.0001<break/>8: Rate of errors because of known allergies decreased 56% from 0.65 to 0.29/1000 patient days, <italic>p</italic> = 0.009</td>
<td>1: <xref ref-type="bibr" rid="bibr16-2042098613477125">Hsieh <italic>et al.</italic> [2004]</xref><break/>2: <xref ref-type="bibr" rid="bibr29-2042098613477125">Kuperman <italic>et al.</italic> [2003a]</xref><break/>3: <xref ref-type="bibr" rid="bibr30-2042098613477125">Kuperman et al. [2003b]</xref><break/>4: <xref ref-type="bibr" rid="bibr31-2042098613477125">Kuperman et al. [2001]</xref><break/>5: <xref ref-type="bibr" rid="bibr28-2042098613477125">Kuperman et al. [1998]</xref><break/>6: <xref ref-type="bibr" rid="bibr1-2042098613477125">Abookire <italic>et al.</italic> [2000]</xref><break/>7: <xref ref-type="bibr" rid="bibr5-2042098613477125">Bates <italic>et al.</italic> [1999]</xref><break/>8: <xref ref-type="bibr" rid="bibr4-2042098613477125">Bates <italic>et al.</italic> [1998]</xref></td>
</tr>
<tr>
<td>HELP (Health Evaluation through Logical Programming)</td>
<td>H</td>
<td>Physician<break/>Pharmacist Nurse</td>
<td>At time of ADE</td>
<td>V</td>
<td>√<break/>lab results, drug level in blood, antidotes, antihistamines, abrupt drug stops</td>
<td>A<break/>ADE</td>
<td>Pha</td>
<td>Pharmacist warns physician</td>
<td>NR</td>
<td>USA</td>
<td>9: Descriptive10-13: Prospective pre-/post- intervention</td>
<td>520-bed private tertiary care hospital</td>
<td>9: 13,727 patients, 88,505 orders<break/>10: 120,213/107,868 patient-days<break/>11: 25,142 patients<break/>12: 25,142/21,963<break/>13: 878 patients</td>
<td>NR</td>
<td>9-12: NR<break/>13: 60</td>
<td>9: 112 alerts on drug allergies<break/>10: During the first year of computerized surveillance in 13/56 (23%) of type B ADEs a previous allergy was documented. In the following 2 years none of the 8 ADEs was due to known allergy.<break/>12: Out of 373 ADEs 56 were type B in the first year of computerized surveillance without alerts. In the next year (with computer alerts) 8 of 560 ADEs were type B. (15% versus 1.4%, <italic>p</italic> &lt; 0.001)<break/>11 and 13: No results</td>
<td>9: <xref ref-type="bibr" rid="bibr17-2042098613477125">Hulse <italic>et al.</italic> [1976]</xref><break/>10: <xref ref-type="bibr" rid="bibr14-2042098613477125">Evans <italic>et al.</italic> [1994]</xref><break/>11: <xref ref-type="bibr" rid="bibr12-2042098613477125">Evans <italic>et al.</italic> [1992]</xref><break/>12: <xref ref-type="bibr" rid="bibr11-2042098613477125">Evans <italic>et al.</italic> [1993]</xref><break/>13: <xref ref-type="bibr" rid="bibr8-2042098613477125">Classen <italic>et al.</italic> [1992]</xref></td>
</tr>
<tr>
<td>MGH’s (Massachusetts General Hospital) CPOE</td>
<td>H</td>
<td>Physician</td>
<td>NR</td>
<td>NR</td>
<td>X</td>
<td>A</td>
<td>Phy</td>
<td>Stop order or override alert (+reason)</td>
<td>NR</td>
<td>USA</td>
<td>2: Descriptive<break/>3: Descriptive</td>
<td>General hospital, part of Partners HealthCare System</td>
<td>NR</td>
<td>NR</td>
<td>NR</td>
<td>No results</td>
<td>2: <xref ref-type="bibr" rid="bibr29-2042098613477125">Kuperman <italic>et al.</italic> [2003a]</xref><break/>3: <xref ref-type="bibr" rid="bibr30-2042098613477125">Kuperman <italic>et al.</italic> [2003b]</xref></td>
</tr>
<tr>
<td>Longitudinal Medical Record</td>
<td>H</td>
<td>Physician, nurses and medical assistants</td>
<td>NR</td>
<td>V</td>
<td>X</td>
<td>A</td>
<td>Phy</td>
<td>Stop order or override alert</td>
<td>NR</td>
<td>USA</td>
<td>2: Descriptive<break/>3: Descriptive</td>
<td>Outpatient practices, part of Partners HealthCare System</td>
<td>NR</td>
<td>NR</td>
<td>NR</td>
<td>No results</td>
<td>2. <xref ref-type="bibr" rid="bibr29-2042098613477125">Kuperman et al. [2003a]</xref><break/>3. <xref ref-type="bibr" rid="bibr30-2042098613477125">Kuperman <italic>et al.</italic> [2003b]</xref></td>
</tr>
<tr>
<td>CPRS<break/>(Computerized Patient Record System) VA Puget Sound</td>
<td>H</td>
<td>Physician Pharmacists<break/>Nurses<break/>Dieticians</td>
<td>NR</td>
<td>V</td>
<td>√<break/>antidotes</td>
<td>A</td>
<td>Phy</td>
<td>Stop order or override alert (only without reason in low-risk alert)</td>
<td>NR</td>
<td>USA</td>
<td>14: Prospective comparison 2001 and 2006<break/>15: Descriptive</td>
<td>VA Puget Sound Health Care System (incl. a teaching hospital, primary<break/>and tertiary care facilities, outpatient clinics and a nursing home)</td>
<td>14: 2001: 42,621 orders. 2006: 37,040 orders<break/>15: NR</td>
<td>NR</td>
<td>NR</td>
<td>14: In 2001 0.25% (105/42,621) generated an allergy alert, of which 72 (69%) were overridden. In 2006 420 of 37,040 (1.13%) orders generated an allergy alert. Of these, 341 (81.2%) were overridden.<break/>15: No results</td>
<td>14: <xref ref-type="bibr" rid="bibr34-2042098613477125">Lin <italic>et al.</italic> [2008]</xref><break/>15: <xref ref-type="bibr" rid="bibr43-2042098613477125">Payne <italic>et al.</italic> [2000]</xref></td>
</tr>
<tr>
<td>Pocketscript</td>
<td>C</td>
<td>Physician Member of the clinician’s<break/>office staff</td>
<td>NR</td>
<td>V</td>
<td>X</td>
<td>A</td>
<td>Phy</td>
<td>Stop or change order or override alert</td>
<td>NR</td>
<td>USA</td>
<td>16: Interview users<break/>17:Retrospective analysis alerts</td>
<td>Small and medium- size group general practices</td>
<td>16: NR<break/>17: 3,570,378 orders</td>
<td>NR</td>
<td>NR</td>
<td>16: No results<break/>17: Allergy alerts accounted for 1.7% of all alerts (3874/233,537). 23% of allergy alerts were accepted.</td>
<td>16: <xref ref-type="bibr" rid="bibr54-2042098613477125">Weingart et al. [2009]</xref><break/>17: <xref ref-type="bibr" rid="bibr19-2042098613477125">Isaac <italic>et al.</italic> [2009]</xref></td>
</tr>
<tr>
<td>Sunrise Clinical Manager</td>
<td>C</td>
<td>Physician<break/>Pharmacist (via an pharmacist system that is linked)</td>
<td>Before prescription</td>
<td>O</td>
<td>X</td>
<td>A</td>
<td>Phy</td>
<td>Stop order or override alert (+reason)</td>
<td>18: Within healthcare facilities<break/>19: NR</td>
<td>18: USA<break/>19: Canada</td>
<td>18: Descriptive<break/>19: Retrospective cohort, pre-/post-intervention</td>
<td>18: Tertiary care academic healthcare facility (incl. 3 hospitals, 40 health care centres, 120 outpatient clinics, university, nursing school)<break/>19: Paediatric hospital, 2 wards</td>
<td>18: NR<break/>19: 6674/5786 patients</td>
<td>18: NR<break/>19: 5.5/6.0</td>
<td>18: NR<break/>19: 45/47</td>
<td>No results</td>
<td>18: <xref ref-type="bibr" rid="bibr7-2042098613477125">Chaffee and Zimmerman [2010]</xref><break/>19: <xref ref-type="bibr" rid="bibr25-2042098613477125">King <italic>et al.</italic> [2003]</xref></td>
</tr>
<tr>
<td>MOXXI (Medical Office for the Twenty First Century)</td>
<td>C</td>
<td>Physician</td>
<td>Moment of discontinuing medication</td>
<td>NR</td>
<td>X</td>
<td>A</td>
<td>Phy Pha</td>
<td>Stop or change order or override alert (+ reason)</td>
<td>Within setting</td>
<td>Canada</td>
<td>Cluster randomized controlled trial</td>
<td>General practices</td>
<td>3449 patients</td>
<td>67</td>
<td>61</td>
<td>No results</td>
<td>20: <xref ref-type="bibr" rid="bibr46-2042098613477125">Tamblyn <italic>et al.</italic> [2008]</xref></td>
</tr>
<tr>
<td>PowerChart, linked to Millennium Pharmnet</td>
<td>C</td>
<td>Physician<break/>Pharmacist<break/>Nurse<break/>Other staff</td>
<td>At admission</td>
<td>V</td>
<td>X</td>
<td>A</td>
<td>Phy<break/>Pha<break/>N</td>
<td>Stop order or override alert (with override reasons for physicians)</td>
<td>NR</td>
<td>USA</td>
<td>Retrospective</td>
<td>Academic hospital</td>
<td>49,887 orders</td>
<td>66</td>
<td>65</td>
<td>Allergy alerts were triggered for 643/49,887 (1.3%) prescriptions, of which 625 (97%) were overridden.</td>
<td>21: <xref ref-type="bibr" rid="bibr18-2042098613477125">Hunteman <italic>et al.</italic> [2009]</xref></td>
</tr>
<tr>
<td>ADE surveillance system</td>
<td>H</td>
<td>Physician<break/>Nurse</td>
<td>At admission</td>
<td>O</td>
<td>X</td>
<td>A<break/>ADE</td>
<td>Phy</td>
<td>NR</td>
<td>The patient receives an allergy card to prevent represcription outside the hospital.</td>
<td>Korea</td>
<td>Pre-/post-intervention</td>
<td>Hospital</td>
<td>20,564/55,432 admissions</td>
<td>51/53</td>
<td>47.5/48</td>
<td>Occurrence rate of re-administration of the agent previously suspected as culprit drug, decreased from 15% to 1%.</td>
<td>22: <xref ref-type="bibr" rid="bibr42-2042098613477125">Park <italic>et al.</italic> [2008]</xref></td>
</tr>
<tr>
<td>Centricity Critical Care Clinisoft, GE Healthcare Europe</td>
<td>C</td>
<td>NR</td>
<td>NR</td>
<td>V</td>
<td>X</td>
<td>A</td>
<td>Phy</td>
<td>NR</td>
<td>NR</td>
<td>Belgium</td>
<td>Prospective controlled cross-sectional trial</td>
<td>22-Bed intensive care unit of a tertiary care hospitals</td>
<td>90 patients 2510 orders</td>
<td>54/61.5</td>
<td>NR</td>
<td>1 med. error by known allergy on the computerized unit <italic>versus</italic> 0 on the paper based unit</td>
<td>23: <xref ref-type="bibr" rid="bibr9-2042098613477125">Colpaert <italic>et al.</italic> [2006]</xref></td>
</tr>
<tr>
<td>Online Medical Record (OMR)</td>
<td>H</td>
<td>Physician Pharmacist<break/>Nurse</td>
<td>NR</td>
<td>V</td>
<td>X</td>
<td>A</td>
<td>Phy</td>
<td>Stop order or override alert</td>
<td>Database is linked to inpatient,<break/>ambulatory and home care settings.</td>
<td>USA</td>
<td>Retrospective</td>
<td>5 Primary care practices and a teaching hospital</td>
<td>GPs: 24,034 orders</td>
<td>NR</td>
<td>70</td>
<td>352/24,034 (1.5%) of GP orders generated allergy alerts, of which 91.2% were overridden</td>
<td>24: <xref ref-type="bibr" rid="bibr55-2042098613477125">Weingart <italic>et al.</italic> [2003]</xref></td>
</tr>
<tr>
<td>Clinical Event Manager (Sunquest)</td>
<td>C</td>
<td>Pharmacist</td>
<td>At admission</td>
<td>V</td>
<td>X</td>
<td>A<break/>ADE</td>
<td>Pha<break/>N</td>
<td>Warn physician</td>
<td>Information is sent to the pharmacy, laboratory, radiology within healthcare system</td>
<td>USA</td>
<td>Descriptive</td>
<td>Large healthcare system (incl. hospitals and ambulant settings)</td>
<td>NR</td>
<td>NR</td>
<td>NR</td>
<td>No results</td>
<td>25: <xref ref-type="bibr" rid="bibr57-2042098613477125">Young [2001]</xref></td>
</tr>
<tr>
<td>Siemens Medical Solutions linked to Pharmacy<break/>Clinical Workstation</td>
<td>C</td>
<td>NR</td>
<td>NR</td>
<td>NR</td>
<td>X</td>
<td>A</td>
<td>Phy Pha</td>
<td>Stop order or override alert</td>
<td>Inside hospital</td>
<td>USA</td>
<td>Pre-post intervention</td>
<td>Two hospitals</td>
<td>1.452,346/1.390,789 medication orders</td>
<td>NR</td>
<td>NR</td>
<td>833 pre- versus 109 post-implementation prescriptions of medication to which the patient has a known allergy. OR 0.14 (0.11–0.17), <italic>p</italic> &lt; 0.001</td>
<td>26: <xref ref-type="bibr" rid="bibr36-2042098613477125">Mahoney <italic>et al.</italic> [2007]</xref></td>
</tr>
<tr>
<td>CPOE system Mayo Clinic</td>
<td>H</td>
<td>NR</td>
<td>NR</td>
<td>NR</td>
<td>X</td>
<td>A</td>
<td>Pha</td>
<td>NR</td>
<td>NR</td>
<td>USA</td>
<td>Retrospective</td>
<td>Outpatient setting of an academic centre</td>
<td>4527 orders</td>
<td>NR</td>
<td>NR</td>
<td>No results</td>
<td>27: <xref ref-type="bibr" rid="bibr53-2042098613477125">Varkey <italic>et al.</italic> [2007]</xref></td>
</tr>
<tr>
<td>MUPS (Massachusetts General Hospital Utility Multi-programming System)</td>
<td>H</td>
<td>Pharmacist (asked by nurse)</td>
<td>At admission</td>
<td>O</td>
<td>X</td>
<td>A<break/>CA<break/>ADE</td>
<td>Pha</td>
<td>Send printed advisory report to physician</td>
<td>Inside hospital</td>
<td>USA</td>
<td>Pilot, descriptive</td>
<td>Inpatient setting of an academic centre</td>
<td>NR</td>
<td>NR</td>
<td>NR</td>
<td>No results</td>
<td>28: <xref ref-type="bibr" rid="bibr48-2042098613477125">Tatro <italic>et al.</italic> [1979]</xref></td>
</tr>
<tr>
<td>EADES (electronic ADE management system)</td>
<td>NR</td>
<td>All medical staff (reviewed by pharmacist)</td>
<td>NR</td>
<td>V</td>
<td>X</td>
<td>A<break/>CA</td>
<td>NR</td>
<td>NR</td>
<td>Inside hospital</td>
<td>Taiwan</td>
<td>Pre-post intervention</td>
<td>Academic hospital</td>
<td>108/394 ADE reports</td>
<td>NR</td>
<td>44/50</td>
<td>No results</td>
<td>29: <xref ref-type="bibr" rid="bibr56-2042098613477125">Yen <italic>et al.</italic> [2010]</xref></td>
</tr>
<tr>
<td>Medicator + Theriak</td>
<td>C + H</td>
<td>NR</td>
<td>NR</td>
<td>NR</td>
<td>X</td>
<td>A</td>
<td>Phy</td>
<td>Stop order or override alert</td>
<td>Inside hospital</td>
<td>The Netherlands</td>
<td>Interrupted time-series design</td>
<td>Two wards in an academic hospital and two wards in another hospital; Internal med, Geriatrics<break/>Gastroenterology/rheumatology</td>
<td>592/603 admissions<break/>7286/7058 orders</td>
<td>65.5/65.1</td>
<td>54.7/56.6</td>
<td>No results</td>
<td>30: <xref ref-type="bibr" rid="bibr52-2042098613477125">Van Doormaal <italic>et al.</italic> [2009]</xref></td>
</tr>
<tr>
<td>System by the ministry of health</td>
<td>H</td>
<td>Physician</td>
<td>NR</td>
<td>V</td>
<td>X</td>
<td>No alert<break/>A</td>
<td>NR</td>
<td>NR</td>
<td>Government hospitals are linked to a central allergy database</td>
<td>Singapore</td>
<td>Descriptive</td>
<td>Nationwide system</td>
<td>NR</td>
<td>NR</td>
<td>NR</td>
<td>No results</td>
<td>31: <xref ref-type="bibr" rid="bibr47-2042098613477125">Tan and Lee [1990]</xref></td>
</tr>
<tr>
<td>EP system (JAC Computer Services Ltd)</td>
<td>C</td>
<td>Physician</td>
<td>Mandatory field on the prescription</td>
<td>O</td>
<td>X</td>
<td>A</td>
<td>Phy</td>
<td>Stop order or override alert (reason optional)</td>
<td>Systems of the pharmacy and the hospital are linked</td>
<td>UK</td>
<td>32. Retrospective<break/>33. Pre-/post-intervention</td>
<td>32. Tertiary care paediatric hospital<break/>33. Renal outpatient clinic</td>
<td>32. 26,836 orders<break/>33. 451/176 patients, 1142 orders</td>
<td>32. NR 33. 8.8/8.9</td>
<td>32. NR<break/>33. 40.2/35.6</td>
<td>32. 71/16,182 (4.4%) of alerts were allergy alerts, of which 45 (63.4%) were overridden.<break/>33. No results</td>
<td>32: <xref ref-type="bibr" rid="bibr21-2042098613477125">Jani et al. [2011]</xref><break/>33: <xref ref-type="bibr" rid="bibr22-2042098613477125">Jani <italic>et al.</italic> [2008]</xref></td>
</tr>
<tr>
<td>HELP+ antibiotics management program</td>
<td>H</td>
<td>Physician<break/>Pharmacist Nurse</td>
<td>At time of ADE</td>
<td>V</td>
<td>X</td>
<td>A<break/>CA</td>
<td>Phy</td>
<td>Stop order or override alert</td>
<td>NR</td>
<td>USA</td>
<td>Prospective study, pre-/post-intervention (anti-infectives)</td>
<td>26-Bed paediatric intensive care unit in an academic hospital</td>
<td>809/949 patients</td>
<td>6.2/5.3</td>
<td>41.5/<break/>43.5</td>
<td>Each group 12 ADEs, with 1 being preventable secondary to known allergy</td>
<td>34: <xref ref-type="bibr" rid="bibr39-2042098613477125">Mullet <italic>et al.</italic> [2001]</xref></td>
</tr>
<tr>
<td>Computerized anti-infectives management program</td>
<td>H</td>
<td>NR</td>
<td>NR</td>
<td>NR</td>
<td>X</td>
<td>A</td>
<td>Phy</td>
<td>Stop order or override alert (+reason)</td>
<td>Program linked to the computer-based<break/>Patient records at hospital</td>
<td>USA</td>
<td>Prospective, pre-/post- intervention (anti-infectives)</td>
<td>12-Bed intensive care unit in a teaching hospital</td>
<td>1136/545<break/>Patients . 942 orders in intervention period</td>
<td>47/48</td>
<td>41/41</td>
<td>146 pre- and 35 post-implementation orders of medications to which patients had reported allergies <italic>p</italic> &lt; 0.01</td>
<td>35: <xref ref-type="bibr" rid="bibr13-2042098613477125">Evans <italic>et al.</italic> [1998]</xref></td>
</tr>
<tr>
<td>Pharmacy information system Duke Hospital</td>
<td>H</td>
<td>Physician<break/>Pharmacist</td>
<td>NR</td>
<td>O</td>
<td>X</td>
<td>A<break/>CA<break/>RA</td>
<td>Pha</td>
<td>NR</td>
<td>Inside hospital</td>
<td>USA</td>
<td>Descriptive</td>
<td>University medical centre</td>
<td>NR</td>
<td>NR</td>
<td>NR</td>
<td>No results</td>
<td>36: <xref ref-type="bibr" rid="bibr35-2042098613477125">Mackowiak and Hayward [1998]</xref></td>
</tr>
<tr>
<td>Unknown</td>
<td>H</td>
<td>Physician</td>
<td>NR</td>
<td>NR</td>
<td>X</td>
<td>A</td>
<td>Pha</td>
<td>NR</td>
<td>Online system between hospital, pharmacy and general practices</td>
<td>USA</td>
<td>Descriptive</td>
<td>Hospital (68 beds), GPs. pharmacists</td>
<td>NR</td>
<td>NR</td>
<td>NR</td>
<td>No results</td>
<td>37: <xref ref-type="bibr" rid="bibr23-2042098613477125">Johnston and Mole [1980]</xref></td>
</tr>
<tr>
<td>Unknown</td>
<td>H</td>
<td>Physician</td>
<td>At admission</td>
<td>O</td>
<td>X</td>
<td>A</td>
<td>Phy</td>
<td>Stop order or override alert (not possible if alert is high risk)</td>
<td>Inside hospital</td>
<td>UK</td>
<td>Retrospective</td>
<td>Nephrology ward of a teaching hospital</td>
<td>1646 patients, 87,789 orders</td>
<td>54.4</td>
<td>41.8</td>
<td>37 prescriptions disallowed because of known allergy</td>
<td>38: <xref ref-type="bibr" rid="bibr40-2042098613477125">Nightingale <italic>et al.</italic> [2000]</xref></td>
</tr>
<tr>
<td>Unknown</td>
<td>H</td>
<td>NR</td>
<td>At admission</td>
<td>O</td>
<td>X</td>
<td>A<break/>CA</td>
<td>Phy</td>
<td>NR</td>
<td>Inside hospital</td>
<td>Israel</td>
<td>Cohort study<break/>(Handwritten and computerized drug order entry)</td>
<td>2 Internal medicine wards of an academic hospital</td>
<td>641/709 patients</td>
<td>70.7/70.8</td>
<td>NR</td>
<td>Drug-allergy prescription errors were similar in handwritten and computerized department: 0.02 errors per patient.</td>
<td>39: <xref ref-type="bibr" rid="bibr41-2042098613477125">Oliven et al. [2005]</xref></td>
</tr>
<tr>
<td>Unknown</td>
<td>H</td>
<td>Physician<break/>Nurse</td>
<td>NR</td>
<td>V</td>
<td>X</td>
<td>A<break/>CA</td>
<td>Phy</td>
<td>NR</td>
<td>Inside hospital</td>
<td>Germany</td>
<td>Cohort study, retrospective</td>
<td>University hospital</td>
<td>200 patients</td>
<td>59</td>
<td>52.5</td>
<td>20% of patients with ICD-10 coded allergy documentation versus 21.6% of patients with manual allergy documentation were prescribed the same culprit drug (<italic>p</italic> = 1.0)</td>
<td>40: <xref ref-type="bibr" rid="bibr6-2042098613477125">Benkhaial <italic>et al.</italic> [2009]</xref></td>
</tr>
</tbody>
</table>
<table-wrap-foot>
<fn id="table-fn1-2042098613477125">
<p>Numbers mentioned in columns refer to the study references (listed in the right-most column).</p>
</fn>
<fn id="table-fn2-2042098613477125">
<p>NR, not reported.</p>
</fn>
<fn id="table-fn3-2042098613477125">
<label>*</label>
<p>C, commercial; H, custom designed.</p>
</fn>
<fn id="table-fn4-2042098613477125">
<label>**</label>
<p>√, present; X, absent.</p>
</fn>
<fn id="table-fn5-2042098613477125">
<label>^</label>
<p>V, voluntary; O, obligatory.</p>
</fn>
<fn id="table-fn6-2042098613477125">
<label>^^</label>
<p>A, allergy; CA, cross-allergy; ADE, adverse drug event; RA, reverse allergy checking.</p>
</fn>
<fn id="table-fn7-2042098613477125">
<label>#</label>
<p>Phy, physician; Pha, pharmacist; N, nurse.</p>
</fn>
<fn id="table-fn8-2042098613477125">
<label>##</label>
<p>if more than one intervention period: data are from last intervention period.</p>
</fn>
</table-wrap-foot>
</table-wrap>
<table-wrap id="table3-2042098613477125" position="float">
<label>Table 3.</label>
<caption>
<p>Characteristics of studies and systems: nonelectronic.</p>
</caption>
<graphic alternate-form-of="table3-2042098613477125" xlink:href="10.1177_2042098613477125-table3.tif"/>
<table>
<colgroup>
<col align="left"/>
<col align="left"/>
<col align="left"/>
<col align="left"/>
<col align="left"/>
<col align="left"/>
<col align="left"/>
<col align="left"/>
<col align="left"/>
<col align="left"/>
<col align="left"/>
<col align="left"/>
<col align="left"/>
<col align="left"/>
</colgroup>
<thead>
<tr>
<th align="left">System method</th>
<th align="left" colspan="5">Characteristics of the system<hr/></th>
<th align="left" colspan="3">Characteristics of the study<hr/></th>
<th/>
<th/>
<th/>
<th align="left">Results<break/>On represcription after the occurrence of an ADE</th>
<th align="left">Reference</th>
</tr>
<tr>
<th/>
<th align="left" colspan="4">Documentation of ADE<hr/></th>
<th align="left">Availability ADE information</th>
<th align="left">Country</th>
<th align="left">Design</th>
<th align="left">Setting</th>
<th align="left" colspan="3">Population<hr/></th>
<th/>
<th/>
</tr>
<tr>
<th/>
<th align="left">By whom</th>
<th align="left">When</th>
<th align="left">How</th>
<th align="left">O/V<xref ref-type="table-fn" rid="table-fn10-2042098613477125">^</xref></th>
<th/>
<th/>
<th/>
<th/>
<th align="left"><italic>N</italic> = Baseline/intervention</th>
<th align="left">Mean age</th>
<th align="left">Gender<break/>%F</th>
<th/>
<th/>
</tr>
</thead>
<tbody>
<tr>
<td>Allergy bracelets and allergy field on drug order</td>
<td>Pharmacy (gets information from physician and nurse)</td>
<td>At admission</td>
<td>A red bracelet for people with an allergy: patient name and medicine on it.<break/>Introduction of an allergy field on each drug order</td>
<td>O</td>
<td>Inside hospital</td>
<td>Canada</td>
<td>Pre-post intervention</td>
<td>General hospital</td>
<td>NR</td>
<td>NR</td>
<td>NR</td>
<td>No results</td>
<td><xref ref-type="bibr" rid="bibr33-2042098613477125">Liguori [1967]</xref></td>
</tr>
<tr>
<td>ADE labels</td>
<td>Physician<break/>Pharmacist<break/>Nurse</td>
<td>During admission</td>
<td>ADE labels on the cover of medical records or drug charts</td>
<td>V</td>
<td>Inside hospital</td>
<td>Australia</td>
<td>Retrospective</td>
<td>Hospital</td>
<td>587 records reviewed</td>
<td>NR</td>
<td>NR</td>
<td>In 31 (20%) of identified ADRs patients were represcribed the culprit medicine despite a ADR label.</td>
<td><xref ref-type="bibr" rid="bibr10-2042098613477125">Dartnell <italic>et al.</italic> [1994]</xref></td>
</tr>
<tr>
<td>Interview by pharmacist</td>
<td>Pharmacist</td>
<td>Within 24 hours after admission</td>
<td>After an interview by the pharmacist a note was made in the medical record and the allergy label on front was corrected</td>
<td>O</td>
<td>Inside hospital</td>
<td>USA</td>
<td>Descriptive</td>
<td>14 Wards and one outpatient clinic of a hospital</td>
<td>195 patients</td>
<td>NR Range 17-87</td>
<td>64</td>
<td>No results</td>
<td><xref ref-type="bibr" rid="bibr44-2042098613477125">Pilzer <italic>et al.</italic> [1996]</xref></td>
</tr>
<tr>
<td>Bracelets and allergy box on drug charts</td>
<td>Nurse (bracelets)<break/>Pharmacist (allergy box)</td>
<td>At admission</td>
<td>White identification bracelets for every patient and red bracelets for allergic patients.<break/>Red allergy box on front of drug chart.</td>
<td>O</td>
<td>Inside hospital</td>
<td>UK</td>
<td>Two cross-sectional studies, pre-post intervention</td>
<td>436-Bed general hospital</td>
<td>186/250 patients</td>
<td>66.8/68.7</td>
<td>62.9/54</td>
<td>No results</td>
<td><xref ref-type="bibr" rid="bibr20-2042098613477125">Ismail <italic>et al.</italic> [2008]</xref></td>
</tr>
<tr>
<td>Allergy information on drug charts and note in medical record</td>
<td>Physician</td>
<td>Before prescription</td>
<td>Allergy information on drug charts and note in medical record</td>
<td>O</td>
<td>Inside hospital</td>
<td>UK</td>
<td>Descriptive</td>
<td>2 Oncology wards of a university hospital</td>
<td>NR</td>
<td>NR</td>
<td>NR</td>
<td>No results</td>
<td><xref ref-type="bibr" rid="bibr37-2042098613477125">Mawby [2006]</xref></td>
</tr>
</tbody>
</table>
<table-wrap-foot>
<fn id="table-fn9-2042098613477125">
<p>ADE, adverse drug event; NR, not reported.</p>
</fn>
<fn id="table-fn10-2042098613477125">
<label>^</label>
<p>V, voluntary; O, obligatory.</p>
</fn>
</table-wrap-foot>
</table-wrap>
</sec>
<sec id="section11-2042098613477125">
<title>Setting</title>
<p>Most systems (21/33 = 64%) were used in an inpatient hospital setting. Five systems were used in general practice or outpatients outpatient departments, six systems were used in combined inpatient and outpatient settings and one was used nationwide in Singapore [<xref ref-type="bibr" rid="bibr47-2042098613477125">Tan and Lee, 1990</xref>].</p>
</sec>
<sec id="section12-2042098613477125">
<title>Documentation of ADEs</title>
<p>The systems differed in how ADEs were documented and how possible represcription of a withdrawn drug was signalled. Eight of 28 electronic systems used automatic detection of ADEs, mostly on the basis of laboratory results and antidotes being ordered.</p>
<p>In most cases, doctors or pharmacists recorded ADEs. A total of 11 of 33 systems recorded known ADEs at admission, and 6 recorded ADEs when the event occurred, when drugs were discontinued or when drugs were ordered. Studies on 12 systems did not mention the timing of ADE registration. The documentation of ADEs was obligatory in 12 systems, such that access to the electronic medication record was blocked until the patients’ ADE history was reported [<xref ref-type="bibr" rid="bibr42-2042098613477125">Park <italic>et al</italic>. 2008</xref>].</p>
</sec>
<sec id="section13-2042098613477125">
<title>Availability of information on ADEs</title>
<p>The information on documented ADEs was mostly available within one healthcare setting (11 systems). Six systems shared this information with different healthcare settings, one system offered an allergy card to the patient [<xref ref-type="bibr" rid="bibr42-2042098613477125">Park <italic>et al</italic>. 2008</xref>] and in one system the information on ADEs was registered in a central allergy database [<xref ref-type="bibr" rid="bibr47-2042098613477125">Tan and Lee, 1990</xref>]. Nine systems did not describe to whom the information on ADEs was made available.</p>
</sec>
<sec id="section14-2042098613477125">
<title>Alerts in case of represcription</title>
<p>In all systems a documented allergy triggered the alert in case of represcription. In seven systems, also a cross-allergy triggered an alert and in five systems other ADEs triggered an alert. Two systems incorporated a reverse allergy check: the current medication list was checked when a new allergy was reported. In the case of represcription after the occurrence of an ADE, 16 systems alerted the physician, 6 systems alerted the pharmacist and 4 systems alerted both physician and pharmacist. In 16 systems, the receiver of the alert could stop the medication order or override the alert (7 with mandatory reporting of the reason to override, 9 without or optional reporting of the reason to override).</p>
<p>The five nonelectronic systems used allergy bracelets or allergy labels on hospital medical records or on drug orders and, as such, information about ADEs was available in the hospital setting.</p>
</sec>
</sec>
<sec id="section15-2042098613477125">
<title>Results on prevention of represcription after the occurrence of an ADE</title>
<p>A total of 19 studies (one involving a nonelectronic system) investigated the effect of these systems for preventing drug represcription after an ADE, with two studies reporting results using BICS [<xref ref-type="bibr" rid="bibr4-2042098613477125">Bates <italic>et al</italic>. 1998</xref>, <xref ref-type="bibr" rid="bibr5-2042098613477125">1999</xref>] and two studies reporting results using the HELP system [<xref ref-type="bibr" rid="bibr11-2042098613477125">Evans <italic>et al</italic>. 1993</xref>, <xref ref-type="bibr" rid="bibr14-2042098613477125">1994</xref>]. Seven of these studies were retrospective or descriptive studies and did not present results for comparisons of pre- and post-intervention period or wards with and without intervention. In these studies, the frequency of allergy alerts ranged from 1.35% to 4.4% of drug orders, and override rates ranged from 44% to 97%. In the study by Dartnell and colleagues in which adverse drug reaction labels were attached to the cover of medical records, the culprit medicine was represcribed in 20% of identified ADEs [<xref ref-type="bibr" rid="bibr10-2042098613477125">Dartnell <italic>et al</italic>. 1994</xref>].</p>
<p>A total of 12 of the 19 studies reported pre- and post-intervention comparisons or compared wards with and without intervention implementation: 7 studies reported that intervention was beneficial and 5 reported that it was not beneficial. None of the studies reported harmful results. The seven studies that reported beneficial results concerned five systems. These systems had no striking shared characteristics.</p>
<p>In a study of the BICS used in a large tertiary care hospital the rate of medication errors in case of known allergy was reduced from 0.65 to 0.29 per 1000 patient-days after introduction of the BICS (<italic>p</italic> = 0.009) [<xref ref-type="bibr" rid="bibr4-2042098613477125">Bates <italic>et al</italic>. 1998</xref>]. A study of the HELP system used in a 530-bed private tertiary care hospital investigated type B ADEs (aberrant effects that are not to be expected from the known pharmacological actions of a drug when given in the usual therapeutic dose; type A effects are predictable and dose dependent) [<xref ref-type="bibr" rid="bibr45-2042098613477125">Rawlins, 1981</xref>]. In this study by Evans and colleagues, a previous allergy was documented in 23% of 56 type B ADEs during the first year of computerized surveillance without alerts [<xref ref-type="bibr" rid="bibr14-2042098613477125">Evans <italic>et al</italic>. 1994</xref>]. In the following 2 years with computerized surveillance with alerts, none of the eight type B ADEs was due to a known allergy. The study by Park and colleagues, involved a ADE surveillance system in which reporting patients’ ADE history was mandatory at admission [<xref ref-type="bibr" rid="bibr42-2042098613477125">Park <italic>et al</italic>. 2008</xref>]. The rate of ADEs caused by re-administration of the suspected culprit drug decreased from 15% (8/54 events) to 1% (1/100 events) after introduction of the surveillance system. After implementation of integrated clinical information technology for CPOE in two hospitals, there were 109 prescriptions of medications to which the patient had a known allergy, compared with 833 such prescriptions before implementation of the system (odds ratio 0.14, 95% confidence interval 0.11–0.17, <italic>p</italic> &lt; 0.001) [<xref ref-type="bibr" rid="bibr36-2042098613477125">Mahoney <italic>et al</italic>. 2007</xref>].</p>
<p>Results of the studies on prevention of represcription after ADE are shown in <xref ref-type="table" rid="table2-2042098613477125">Table 2</xref> (electronic systems) and <xref ref-type="table" rid="table3-2042098613477125">Table 3</xref> (nonelectronic systems).</p>
</sec>
</sec>
<sec id="section16-2042098613477125" sec-type="discussion">
<title>Discussion</title>
<p>We identified 45 articles that described 33 systems that can prevent the represcription of drugs that were withdrawn because they caused an ADE. Five of these systems were nonelectronic and 28 electronic. The nonelectronic systems used allergy bracelets or allergy labels on hospital medical records or on drug orders. The systems differed in the way ADEs were documented (when, by whom, obligatory or voluntary) and in the alerts that occurred if drugs were represcribed after an ADE. The represcription alerts were mostly triggered by allergies and cross-allergies only and not by other ADEs. In 11 systems the information on ADEs was available in one setting only, in 6 systems the information on ADEs was shared with different healthcare settings. None of the studies on nonelectronic studies showed results comparing pre- and post-intervention. Twelve of the studies on electronic systems reported pre- and post-intervention comparisons or compared wards with and without intervention implementation, with seven studies reporting beneficial results. These studies differed substantially in terms of patient population, intervention and measurements methods, which made it difficult to compare results of the studies. Only nine studies were primarily designed to measure results on prevention of represcription after the occurrence of an ADE.</p>
<p>Preventable ADEs, of which known allergic reactions represent an important fraction, frequently occur. In a study of inpatient medication errors, 8% of errors were preventable because it was known at the time of prescription that the patient was allergic to the medication being ordered [<xref ref-type="bibr" rid="bibr32-2042098613477125">Leape <italic>et al</italic>. 1995</xref>]. In a comparable study involving outpatients, 13% of ADEs were caused by patient receiving medications to which they had a known allergy [<xref ref-type="bibr" rid="bibr15-2042098613477125">Gandhi <italic>et al</italic>. 2000</xref>]. One study [<xref ref-type="bibr" rid="bibr29-2042098613477125">Kuperman <italic>et al</italic>. 2003a</xref>] even recommended the development of a computer system that can prevent reactions due to known allergies. The current study reviewed systems that can help to prevent the represcription of drugs withdrawn because they caused an ADE.</p>
<p>Differences in the terminology used to describe the various systems made it difficult to search the literature. Furthermore, many of the studies retrieved investigated surveillance systems from a much broader objective than only prevention of represcription of withdrawn drugs, for example the effect of a CPOE system on medication errors in general. It was not possible to fully follow PRISMA and Cochrane guidelines because of the strong heterogeneity of the studies for example in design and outcome measures. More studies involved electronic systems. There might be a reporting bias in two ways: more recently, more attention has been paid to the described problem and more recent studies focus on electronic systems. A limitation of the current study is the fact that bias was not assessed in all studies.</p>
<p>To prevent represcription of drugs withdrawn because of an ADE at a patient level we suggest to improve quality of documentation of ADEs, preferably including causality assessment, which necessitates cooperation between physicians and pharmacists. Underreporting of ADEs is a known risk and we suggest that the effect of compulsory documentation and timing is researched, with a view to minimizing underreporting. Automatic detection of ADEs on the basis of laboratory results or antidotes orders might also be of help to prevent underreporting. As most systems only document and flag allergies, but not other types of ADEs, it is important to report all ADEs in patient files. Only two systems allowed reverse allergy checking which would seem a logical step optimize medication safety. Future systems should function in more than one setting and make information on ADEs and alerts available to all relevant healthcare professionals (GP, pharmacist, specialist) and the patient. Another concern is the high rate of alert override rates in the case of allergy. Reasons to override mentioned by physicians in the selected studies are for example: ‘patient previously tolerated medication’ and ‘benefit outweighed the risk’. [<xref ref-type="bibr" rid="bibr18-2042098613477125">Hunteman <italic>et al</italic>. 2009</xref>]. Van der Sijs and colleagues concluded in their review of drug safety order check studies that insufficient sensitivity and specificity of order checks results in high override rates [<xref ref-type="bibr" rid="bibr51-2042098613477125">Van der Sijs <italic>et al</italic>. 2006</xref>]. We think the reasons to override an alert should be documented, so that pharmacotherapeutic choices can be evaluated retrospectively. Alerts should be given in a selective and effective way, preventing alert fatigue and overriding.</p>
</sec>
<sec id="section17-2042098613477125" sec-type="conclusions">
<title>Conclusion</title>
<p>Multiple systems, mostly electronic combining CPOE with DSS, have been developed to prevent the represcription of drugs withdrawn because of an ADE, but there is limited evidence that these systems are effective. Future systems should optimize the quality and frequency of ADE documentation, the availability of such information to all relevant healthcare providers, and the flagging of represcription of drugs withdrawn because they caused an ADE. Future research will have to show the value of these systems to patient care.</p>
</sec>
</body>
<back>
<ack><p>C.M.J. van der Linden was financially supported by Catharina Hospital’s Science Fund. The Catharina Hospital’s Science Fund had no role in any of the following: design and conduct of the study; collection, management, analysis, and interpretation of the data; preparation, review or approval of the manuscript.</p></ack>
<fn-group>
<fn fn-type="conflict">
<label>Conflict of interest statement</label>
<p>All authors declare that they have no conflicts of interest, including specific financial interests and relationships and affiliations relevant to the subject matter or materials discussed in the manuscript.</p>
</fn>
</fn-group>
<ref-list>
<title>References</title>
<ref id="bibr1-2042098613477125">
<citation citation-type="confproc">
<person-group person-group-type="author">
<name><surname>Abookire</surname><given-names>S.</given-names></name>
<name><surname>Teich</surname><given-names>J.</given-names></name>
<name><surname>Sandige</surname><given-names>H.</given-names></name>
<name><surname>Paterno</surname><given-names>M.</given-names></name>
<name><surname>Martin</surname><given-names>M.</given-names></name>
<name><surname>Kuperman</surname><given-names>G.</given-names></name><etal/>
</person-group>. (<year>2000</year>) <article-title>Improving allergy alerting in a computerized physician order entry system</article-title>. In: <conf-name>Proceedings American Medical Informatics Association Symposium</conf-name>, pp. <fpage>2</fpage>–<lpage>6</lpage>.</citation>
</ref>
<ref id="bibr2-2042098613477125">
<citation citation-type="book">
<person-group person-group-type="author">
<name><surname>Aspden</surname><given-names>P.</given-names></name>
<name><surname>Wolcott</surname><given-names>J.</given-names></name>
<name><surname>Bootman</surname><given-names>J.</given-names></name>
<name><surname>Cronenwett</surname><given-names>L.</given-names></name>
</person-group> (<year>2006</year>) <source>Preventing Medication Errors: Quality Chasm Series</source>. <publisher-loc>Washington, DC</publisher-loc>: <publisher-name>National Academy Press</publisher-name>.</citation>
</ref>
<ref id="bibr3-2042098613477125">
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Bates</surname><given-names>D.</given-names></name>
<name><surname>Cullen</surname><given-names>D.</given-names></name>
<name><surname>Laird</surname><given-names>N.</given-names></name>
<name><surname>Petersen</surname><given-names>L.</given-names></name>
<name><surname>Small</surname><given-names>S.</given-names></name>
<name><surname>Servi</surname><given-names>D.</given-names></name><etal/>
</person-group>. (<year>1995</year>) <article-title>Incidence of adverse drug events and potential adverse drug events. Implications for prevention</article-title>. <source>J Am Med Assoc</source> <volume>274</volume>: <fpage>29</fpage>–<lpage>34</lpage>.</citation>
</ref>
<ref id="bibr4-2042098613477125">
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Bates</surname><given-names>D.</given-names></name>
<name><surname>Leape</surname><given-names>L.</given-names></name>
<name><surname>Cullen</surname><given-names>D.</given-names></name>
<name><surname>Laird</surname><given-names>N.</given-names></name>
<name><surname>Petersen</surname><given-names>L.</given-names></name>
<name><surname>Teich</surname><given-names>J.</given-names></name><etal/>
</person-group>. (<year>1998</year>) <article-title>Effect of computerized physician order entry and a team intervention on prevention of serious medication errors</article-title>. <source>J Am Med Informat Assoc</source> <volume>280</volume>: <fpage>1311</fpage>–<lpage>1316</lpage>.</citation>
</ref>
<ref id="bibr5-2042098613477125">
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Bates</surname><given-names>D.</given-names></name>
<name><surname>Teich</surname><given-names>J.</given-names></name>
<name><surname>Lee</surname><given-names>J.</given-names></name>
<name><surname>Seger</surname><given-names>D.</given-names></name>
<name><surname>Kuperman</surname><given-names>G.</given-names></name>
<name><surname>Ma’Luf</surname><given-names>N.</given-names></name><etal/>
</person-group>. (<year>1999</year>) <article-title>The impact of computerized physician order entry on medication error prevention</article-title>. <source>J Am Med Informat Assoc</source> <volume>6</volume>: <fpage>313</fpage>–<lpage>321</lpage>.</citation>
</ref>
<ref id="bibr6-2042098613477125">
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Benkhaial</surname><given-names>A.</given-names></name>
<name><surname>Kaltschmidt</surname><given-names>J.</given-names></name>
<name><surname>Weisshaar</surname><given-names>E.</given-names></name>
<name><surname>Diepgen</surname><given-names>T.</given-names></name>
<name><surname>Haefeli</surname><given-names>W.</given-names></name>
</person-group> (<year>2009</year>) <article-title>Prescribing errors in patients with documented drug allergies: comparison of ICD–10 coding and written patient notes</article-title>. <source>Pharm World Sci</source> <volume>31</volume>: <fpage>464</fpage>–<lpage>472</lpage>.</citation>
</ref>
<ref id="bibr7-2042098613477125">
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Chaffee</surname><given-names>B.</given-names></name>
<name><surname>Zimmerman</surname><given-names>C.</given-names></name>
</person-group> (<year>2010</year>) <article-title>Developing and implementing clinical decision support for use in a computerized prescriber-order-entry system</article-title>. <source>Am J Health-Syst Pharm</source> <volume>67</volume>: <fpage>391</fpage>–<lpage>400</lpage>.</citation>
</ref>
<ref id="bibr8-2042098613477125">
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Classen</surname><given-names>D.</given-names></name>
<name><surname>Pestotnik</surname><given-names>S.</given-names></name>
<name><surname>Evans</surname><given-names>R.</given-names></name>
<name><surname>Burke</surname><given-names>J.</given-names></name>
</person-group> (<year>1992</year>) <article-title>Description of a computerized adverse drug event monitor using a hospital information system</article-title>. <source>Hospital Pharm</source> <volume>27</volume>: <volume>774</volume>, <fpage>776</fpage>–<lpage>779</lpage>, <fpage>783</fpage>.</citation>
</ref>
<ref id="bibr9-2042098613477125">
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Colpaert</surname><given-names>K.</given-names></name>
<name><surname>Claus</surname><given-names>B.</given-names></name>
<name><surname>Somers</surname><given-names>A.</given-names></name>
<name><surname>Vandewoude</surname><given-names>K.</given-names></name>
<name><surname>Robays</surname><given-names>H.</given-names></name>
<name><surname>Decruyenaere</surname><given-names>J.</given-names></name>
</person-group> (<year>2006</year>) <article-title>Impact of computerized physician order entry on medication prescription errors in the intensive care unit: a controlled cross-sectional trial</article-title>. <source>Crit Care</source> <volume>10</volume>(<issue>1</issue>): <fpage>R21</fpage>.</citation>
</ref>
<ref id="bibr10-2042098613477125">
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Dartnell</surname><given-names>J.</given-names></name>
<name><surname>Crowe</surname><given-names>D.</given-names></name>
<name><surname>Schubert</surname><given-names>A.</given-names></name>
<name><surname>Moulds</surname><given-names>R.</given-names></name>
</person-group> (<year>1994</year>) <article-title>Review of the use of adverse drug reaction labels on medical records</article-title>. <source>Austral J Hospital Pharm</source> <volume>24</volume>: <fpage>333</fpage>–<lpage>335</lpage>.</citation>
</ref>
<ref id="bibr11-2042098613477125">
<citation citation-type="confproc">
<person-group person-group-type="author">
<name><surname>Evans</surname><given-names>R.</given-names></name>
<name><surname>Pestotnik</surname><given-names>S.</given-names></name>
<name><surname>Classen</surname><given-names>D.</given-names></name>
<name><surname>Bass</surname><given-names>S.</given-names></name>
<name><surname>Burke</surname><given-names>J.</given-names></name>
</person-group> (<year>1993</year>) <article-title>Prevention of adverse drug events through computerized surveillance</article-title>. In: <conf-name>Proceedings of the Annual Symposium on Computer Applications in Medical Care</conf-name>, pp. <fpage>437</fpage>–<lpage>441</lpage>.</citation>
</ref>
<ref id="bibr12-2042098613477125">
<citation citation-type="confproc">
<person-group person-group-type="author">
<name><surname>Evans</surname><given-names>R.</given-names></name>
<name><surname>Pestotnik</surname><given-names>S.</given-names></name>
<name><surname>Classen</surname><given-names>D.</given-names></name>
<name><surname>Bass</surname><given-names>S.</given-names></name>
<name><surname>Menlove</surname><given-names>R.</given-names></name>
<name><surname>Gardner</surname><given-names>R.</given-names></name><etal/>
</person-group>. (<year>1992</year>) <article-title>Development of a computerized adverse drug event monitor</article-title>. In: <conf-name>Proceedings of the Annual Symposium on Computer Applications in Medical Care</conf-name>, pp. <fpage>23</fpage>–<lpage>27</lpage>.</citation>
</ref>
<ref id="bibr13-2042098613477125">
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Evans</surname><given-names>R.</given-names></name>
<name><surname>Pestotnik</surname><given-names>S.</given-names></name>
<name><surname>Classen</surname><given-names>D.</given-names></name>
<name><surname>Clemmer</surname><given-names>T.</given-names></name>
<name><surname>Weaver</surname><given-names>L.</given-names></name>
<name><surname>Orme</surname><given-names>J.</given-names></name><etal/>
</person-group>. (<year>1998</year>) <article-title>A computer-assisted management program for antibiotics and other antiinfective agents</article-title>. <source>N Engl J Med</source> <volume>338</volume>: <fpage>232</fpage>–<lpage>238</lpage>.</citation>
</ref>
<ref id="bibr14-2042098613477125">
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Evans</surname><given-names>R.</given-names></name>
<name><surname>Pestotnik</surname><given-names>S.</given-names></name>
<name><surname>Classen</surname><given-names>D.</given-names></name>
<name><surname>Horn</surname><given-names>S.</given-names></name>
<name><surname>Bass</surname><given-names>S.</given-names></name>
<name><surname>Burke</surname><given-names>J.</given-names></name>
</person-group> (<year>1994</year>) <article-title>Preventing adverse drug events in hospitalized patients</article-title>. <source>Ann Pharmacother</source> <volume>28</volume>: <fpage>523</fpage>–<lpage>527</lpage>.</citation>
</ref>
<ref id="bibr15-2042098613477125">
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Gandhi</surname><given-names>T.</given-names></name>
<name><surname>Burstin</surname><given-names>H.</given-names></name>
<name><surname>Cook</surname><given-names>E.</given-names></name>
<name><surname>Puopolu</surname><given-names>A.</given-names></name>
<name><surname>Haas</surname><given-names>J.</given-names></name>
<name><surname>Brennan</surname><given-names>T.</given-names></name><etal/>
</person-group>. (<year>2000</year>) <article-title>Drug complications in outpatients</article-title>. <source>J Gen Intern Med</source> <volume>15</volume>: <fpage>149</fpage>–<lpage>154</lpage>.</citation>
</ref>
<ref id="bibr16-2042098613477125">
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Hsieh</surname><given-names>T.</given-names></name>
<name><surname>Kuperman</surname><given-names>G.</given-names></name>
<name><surname>Jaggi</surname><given-names>T.</given-names></name>
<name><surname>Hojnowski-Diaz</surname><given-names>P.</given-names></name>
<name><surname>Fiskio</surname><given-names>J.</given-names></name>
<name><surname>Williams</surname><given-names>D.</given-names></name><etal/>
</person-group>. (<year>2004</year>) <article-title>Characteristics and consequences of drug allergy alert overrides in a computerized physician order entry system</article-title>. <source>J Am Med Informat Assoc</source> <volume>11</volume>: <fpage>482</fpage>–<lpage>491</lpage>.</citation>
</ref>
<ref id="bibr17-2042098613477125">
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Hulse</surname><given-names>R.</given-names></name>
<name><surname>Clark</surname><given-names>S.</given-names></name>
<name><surname>Jackson</surname><given-names>J.</given-names></name>
<name><surname>Warner</surname><given-names>H.</given-names></name>
<name><surname>Gardner</surname><given-names>R.</given-names></name>
</person-group> (<year>1976</year>) <article-title>Computerized medication monitoring system</article-title>. <source>Am J Hospital Pharm</source> <volume>33</volume>: <fpage>1061</fpage>–<lpage>1064</lpage>.</citation>
</ref>
<ref id="bibr18-2042098613477125">
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Hunteman</surname><given-names>L.</given-names></name>
<name><surname>Ward</surname><given-names>L.</given-names></name>
<name><surname>Read</surname><given-names>D.</given-names></name>
<name><surname>Jolly</surname><given-names>M.</given-names></name>
<name><surname>Heckman</surname><given-names>M.</given-names></name>
</person-group> (<year>2009</year>) <article-title>Analysis of allergy alerts within a computerized prescriber-order-entry system</article-title>. <source>Am J Health-Syst Pharm</source> <volume>66</volume>: <fpage>373</fpage>–<lpage>377</lpage>.</citation>
</ref>
<ref id="bibr19-2042098613477125">
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Isaac</surname><given-names>T.</given-names></name>
<name><surname>Weissman</surname><given-names>J.</given-names></name>
<name><surname>Davis</surname><given-names>R.</given-names></name>
<name><surname>Davis</surname><given-names>R.</given-names></name>
<name><surname>Massagli</surname><given-names>M.</given-names></name>
<name><surname>Cyrulik</surname><given-names>A.</given-names></name><etal/>
</person-group>. (<year>2009</year>) <article-title>Overrides of medication alerts in ambulatory care</article-title>. <source>Arch Intern Med</source> <volume>169</volume>: <fpage>305</fpage>–<lpage>311</lpage>.</citation>
</ref>
<ref id="bibr20-2042098613477125">
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Ismail</surname><given-names>Z.</given-names></name>
<name><surname>Ismail</surname><given-names>T.</given-names></name>
<name><surname>Wilson</surname><given-names>A.</given-names></name>
</person-group> (<year>2008</year>) <article-title>Improving safety for patients with allergies: an intervention for improving allergy documentation</article-title>. <source>Clin Governance</source> <volume>13</volume>(<issue>2</issue>): <fpage>86</fpage>–<lpage>94</lpage>.</citation>
</ref>
<ref id="bibr21-2042098613477125">
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Jani</surname><given-names>Y.</given-names></name>
<name><surname>Barber</surname><given-names>N.</given-names></name>
<name><surname>Wong</surname><given-names>I.</given-names></name>
</person-group> (<year>2011</year>) <article-title>Characteristics of clinical decision support alert overrides in an electronic prescribing system at a tertiary care paediatric hospital</article-title>. <source>Int J Pharm Practice</source> <volume>19</volume>: <fpage>363</fpage>–<lpage>366</lpage>.</citation>
</ref>
<ref id="bibr22-2042098613477125">
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Jani</surname><given-names>Y.</given-names></name>
<name><surname>Ghaleb</surname><given-names>M.</given-names></name>
<name><surname>Marks</surname><given-names>S.</given-names></name>
<name><surname>Cope</surname><given-names>J.</given-names></name>
<name><surname>Barber</surname><given-names>N.</given-names></name>
<name><surname>Wong</surname><given-names>I.</given-names></name>
</person-group> (<year>2008</year>) <article-title>Electronic prescribing reduced prescribing errors in a pediatric renal outpatient clinic</article-title>. <source>J Pediatrics</source> <volume>152</volume>: <fpage>214</fpage>–<lpage>218</lpage>.</citation>
</ref>
<ref id="bibr23-2042098613477125">
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Johnston</surname><given-names>C.</given-names></name>
<name><surname>Mole</surname><given-names>A.</given-names></name>
</person-group> (<year>1980</year>) <article-title>Patient care computer in 68-bed hospital</article-title>. <source>J Am Med Record Assoc</source> <volume>51</volume>(<issue>4</issue>): <fpage>28</fpage>–<lpage>36</lpage>.</citation>
</ref>
<ref id="bibr24-2042098613477125">
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Khalil</surname><given-names>H.</given-names></name>
<name><surname>Leversha</surname><given-names>A.</given-names></name>
<name><surname>Khalil</surname><given-names>V.</given-names></name>
</person-group> (<year>2011</year>) <article-title>Drug allergy documentation-time for a change?</article-title> <source>Int J Clin Pharmacol</source> <volume>33</volume>: <fpage>610</fpage>–<lpage>613</lpage>.</citation>
</ref>
<ref id="bibr25-2042098613477125">
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>King</surname><given-names>W.</given-names></name>
<name><surname>Paice</surname><given-names>N.</given-names></name>
<name><surname>Rangrej</surname><given-names>J., Forestell, G. J. and Swartz R.</given-names></name>
</person-group> (<year>2003</year>) <article-title>The effect of computerized physician order entry on medication errors and adverse drug events in pediatric inpatients</article-title>. <source>Pediatrics</source> <volume>112</volume>: <fpage>506</fpage>–<lpage>509</lpage>.</citation>
</ref>
<ref id="bibr26-2042098613477125">
<citation citation-type="book">
<person-group person-group-type="author">
<name><surname>Kohn</surname><given-names>L.</given-names></name>
<name><surname>Corrigan</surname><given-names>J.</given-names></name>
<name><surname>Donaldson</surname><given-names>M.</given-names></name>
</person-group> (<year>1999</year>) <source>To Err is Human: Building a Safer Health System</source>. <publisher-loc>Washington, DC</publisher-loc>: <publisher-name>National Academy Press</publisher-name></citation>
</ref>
<ref id="bibr27-2042098613477125">
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Kuperman</surname><given-names>G.</given-names></name>
<name><surname>Bobb</surname><given-names>A.</given-names></name>
<name><surname>Payne</surname><given-names>T.</given-names></name>
<name><surname>Avery</surname><given-names>A.J.</given-names></name>
<name><surname>Gandhi</surname><given-names>T.K.</given-names></name>
<name><surname>Burns</surname><given-names>G.</given-names></name><etal/>
</person-group>. (<year>2007</year>) <article-title>Medication-related clinical decision support in computerized provider order entry systems: a review</article-title>. <source>J Am Med Informat Assoc</source> <volume>14</volume>: <fpage>29</fpage>–<lpage>40</lpage>.</citation>
</ref>
<ref id="bibr28-2042098613477125">
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Kuperman</surname><given-names>G.</given-names></name>
<name><surname>Cooley</surname><given-names>T.</given-names></name>
<name><surname>Tremblay</surname><given-names>J.</given-names></name>
<name><surname>Teich</surname><given-names>J.M.</given-names></name>
<name><surname>Churchill</surname><given-names>W.</given-names></name>
</person-group> (<year>1998</year>) <article-title>Decision support for medication use in an inpatient physician order entry application and a pharmacy application</article-title>. <source>Stud Health Technol Informat</source> <volume>52</volume>: <fpage>467</fpage>–<lpage>471</lpage>.</citation>
</ref>
<ref id="bibr29-2042098613477125">
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Kuperman</surname><given-names>G.</given-names></name>
<name><surname>Gandhi</surname><given-names>T.</given-names></name>
<name><surname>Bates</surname><given-names>D.</given-names></name>
</person-group> (<year>2003a</year>) <article-title>Effective drug-allergy checking: methodological and operational issues</article-title>. <source>J Biomed Informat</source> <volume>36</volume>: <fpage>70</fpage>–<lpage>79</lpage>.</citation>
</ref>
<ref id="bibr30-2042098613477125">
<citation citation-type="confproc">
<person-group person-group-type="author">
<name><surname>Kuperman</surname><given-names>G.</given-names></name>
<name><surname>Marston</surname><given-names>E.</given-names></name>
<name><surname>Paterno</surname><given-names>M.</given-names></name><etal/>
</person-group>. (<year>2003b</year>) <article-title>Creating an enterprise-wide allergy repository at Partners HealthCare System</article-title>. In <conf-name>Proceedings American Medical Informatics Association Annual Symposium</conf-name>, pp. <fpage>376</fpage>–<lpage>380</lpage>.</citation>
</ref>
<ref id="bibr31-2042098613477125">
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Kuperman</surname><given-names>G.</given-names></name>
<name><surname>Teich</surname><given-names>J.</given-names></name>
<name><surname>Gandhi</surname><given-names>T.</given-names></name><etal/>
</person-group>. (<year>2001</year>) <article-title>Patient safety and computerized medication ordering at Brigham and Women’s Hospital</article-title>. <source>Joint Commission J Qual Improvement</source> <volume>27</volume>: <fpage>509</fpage>–<lpage>521</lpage>.</citation>
</ref>
<ref id="bibr32-2042098613477125">
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Leape</surname><given-names>L.</given-names></name>
<name><surname>Bates</surname><given-names>D.</given-names></name>
<name><surname>Cullen</surname><given-names>D.</given-names></name>
<name><surname>Cooper</surname><given-names>J.</given-names></name>
<name><surname>Demonaco</surname><given-names>H. J.</given-names></name>
<name><surname>Gallivan</surname><given-names>T.</given-names></name><etal/>
</person-group>. (<year>1995</year>) <article-title>Systems analysis of adverse drug events. ADE Prevention Study Group</article-title>. <source>Journal of the American Medical Association</source> <volume>274</volume>(<issue>1</issue>): <fpage>35</fpage>–<lpage>43.</lpage></citation>
</ref>
<ref id="bibr33-2042098613477125">
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Liguori</surname><given-names>M.</given-names></name>
</person-group> (<year>1967</year>) <article-title>Drug allergy alert program</article-title>. <source>Canadian Hospital</source> <volume>44</volume>(<issue>3</issue>): <fpage>25</fpage>–<lpage>27</lpage>.</citation>
</ref>
<ref id="bibr34-2042098613477125">
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Lin</surname><given-names>C.</given-names></name>
<name><surname>Payne</surname><given-names>T.</given-names></name>
<name><surname>Nichol</surname><given-names>W.</given-names></name>
<name><surname>Hoey</surname><given-names>P.</given-names></name>
<name><surname>Anderson</surname><given-names>C. L.</given-names></name>
<name><surname>Gennari</surname><given-names>J.H.</given-names></name><etal/>
</person-group>. (<year>2008</year>) <article-title>Evaluating clinical decision support systems: monitoring CPOE order check override rates in the Department of Veterans Affairs’ Computerized Patient Record System</article-title>. <source>J Am Med Informat Assoc</source> <volume>15</volume>: <fpage>620</fpage>–<lpage>626</lpage>.</citation>
</ref>
<ref id="bibr35-2042098613477125">
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Mackowiak</surname><given-names>L.</given-names></name>
<name><surname>Hayward</surname><given-names>S.</given-names></name>
</person-group> (<year>1998</year>) <article-title>Issues of decision support in institutional pharmacy systems</article-title>. <source>Pharm Practice Management Q</source> <volume>18</volume>(<issue>1</issue>): <fpage>35</fpage>–<lpage>45</lpage>.</citation>
</ref>
<ref id="bibr36-2042098613477125">
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Mahoney</surname><given-names>C.</given-names></name>
<name><surname>Berard-Collins</surname><given-names>C.</given-names></name>
<name><surname>Coleman</surname><given-names>R.</given-names></name>
<name><surname>Amaral</surname><given-names>J. F.</given-names></name>
<name><surname>Cotter</surname><given-names>C. M.</given-names></name>
</person-group> (<year>2007</year>) <article-title>Effects of an integrated clinical information system on medication safety in a multi-hospital setting</article-title>. <source>Am J Health-Syst Pharm</source> <volume>64</volume>: <fpage>1969</fpage>–<lpage>1977</lpage>.</citation>
</ref>
<ref id="bibr37-2042098613477125">
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Mawby</surname><given-names>J.</given-names></name>
</person-group> (<year>2006</year>) <article-title>Accurate documenting of a patient’s drug allergy status will promote informed therapy decision-making</article-title>. <source>Pharm Practice</source> <volume>16</volume>(<issue>1</issue>): <fpage>24</fpage>–<lpage>25</lpage>.</citation>
</ref>
<ref id="bibr38-2042098613477125">
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Moher</surname><given-names>D.</given-names></name>
<name><surname>Liberati</surname><given-names>A.</given-names></name>
<name><surname>Tetzlaff</surname><given-names>J.</given-names></name><etal/>
</person-group>. (<year>2009</year>) <article-title>PRISMA Group. Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement</article-title>. <source>Br Med J</source> <volume>339</volume>: <fpage>b2535</fpage>.</citation>
</ref>
<ref id="bibr39-2042098613477125">
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Mullett</surname><given-names>C.</given-names></name>
<name><surname>Evans</surname><given-names>R.</given-names></name>
<name><surname>Christenson</surname><given-names>J.</given-names></name><etal/>
</person-group>. (<year>2001</year>) <article-title>Development and impact of a computerized pediatric antiinfective decision support program</article-title>. <source>Pediatrics</source> <volume>108</volume>(<issue>4</issue>): <fpage>e75</fpage>.</citation>
</ref>
<ref id="bibr40-2042098613477125">
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Nightingale</surname><given-names>P.</given-names></name>
<name><surname>Adu</surname><given-names>D.</given-names></name>
<name><surname>Richards</surname><given-names>N.</given-names></name><etal/>
</person-group>. (<year>2000</year>) <article-title>Implementation of rules based computerised bedside prescribing and administration: intervention study</article-title>. <source>Br Med J</source> <volume>320</volume>: <fpage>750</fpage>–<lpage>753</lpage>.</citation>
</ref>
<ref id="bibr41-2042098613477125">
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Oliven</surname><given-names>A.</given-names></name>
<name><surname>Michalakea</surname><given-names>I.</given-names></name>
<name><surname>Zalmana</surname><given-names>D.</given-names></name><etal/>
</person-group>. (<year>2005</year>) <article-title>Prevention of prescription errors by computerized, on-line surveillance of drug order entry</article-title>. <source>Int J Med Informat</source> <volume>74</volume>: <fpage>377</fpage>–<lpage>386</lpage>.</citation>
</ref>
<ref id="bibr42-2042098613477125">
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Park</surname><given-names>C.</given-names></name>
<name><surname>Kim</surname><given-names>T.</given-names></name>
<name><surname>Kim</surname><given-names>S.</given-names></name><etal/>
</person-group>. (<year>2008</year>) <article-title>The use of an electronic medical record system for mandatory reporting of drug hypersensitivity reactions has been shown to improve the management of patients in the university hospital in Korea</article-title>. <source>Pharmacoepidemiol Drug Safety</source> <volume>17</volume>: <fpage>919</fpage>–<lpage>925</lpage>.</citation>
</ref>
<ref id="bibr43-2042098613477125">
<citation citation-type="confproc">
<person-group person-group-type="author">
<name><surname>Payne</surname><given-names>T.</given-names></name>
<name><surname>Savarino</surname><given-names>J.</given-names></name>
<name><surname>Marshall</surname><given-names>R.</given-names></name><etal/>
</person-group>. (<year>2000</year>) <article-title>Use of a clinical event monitor to prevent and detect medication errors</article-title>. In <conf-name>Proceedings American Medical Informatics Association Symposium</conf-name>, pp. <fpage>640</fpage>–<lpage>644</lpage>.</citation>
</ref>
<ref id="bibr44-2042098613477125">
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Pilzer</surname><given-names>J.</given-names></name>
<name><surname>Burke</surname><given-names>T.</given-names></name>
<name><surname>Mutnick</surname><given-names>A.</given-names></name>
</person-group> (<year>1996</year>) <article-title>Drug allergy assessment at a university hospital and clinic</article-title>. <source>Am J Health-Syst Pharm</source> <volume>53</volume>: <fpage>2970</fpage>–<lpage>2975</lpage>.</citation>
</ref>
<ref id="bibr45-2042098613477125">
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Rawlins</surname><given-names>M.</given-names></name>
</person-group> (<year>1981</year>) <article-title>Clinical pharmacology: adverse reactions to drugs</article-title>. <source>Br Med J</source> <volume>282</volume>: <fpage>974</fpage>–<lpage>976</lpage>.</citation>
</ref>
<ref id="bibr46-2042098613477125">
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Tamblyn</surname><given-names>R.</given-names></name>
<name><surname>Huang</surname><given-names>A.</given-names></name>
<name><surname>Taylor</surname><given-names>L.</given-names></name><etal/>
</person-group>. (<year>2008</year>) <article-title>A randomized trial of the effectiveness of on-demand versus computer-triggered drug decision support in primary care</article-title>. <source>J Am Med Informat Assoc</source> <volume>15</volume>: <fpage>430</fpage>–<lpage>438</lpage>.</citation>
</ref>
<ref id="bibr47-2042098613477125">
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Tan</surname><given-names>L.</given-names></name>
<name><surname>Lee</surname><given-names>A.</given-names></name>
</person-group> (<year>1990</year>) <article-title>Hospital based drug allergy register in Singapore</article-title>. <source>Ann Acad Med Singapore</source> <volume>19</volume>: <fpage>666</fpage>–<lpage>671</lpage>.</citation>
</ref>
<ref id="bibr48-2042098613477125">
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Tatro</surname><given-names>D.</given-names></name>
<name><surname>Moore</surname><given-names>T.</given-names></name>
<name><surname>Cohen</surname><given-names>S.</given-names></name>
</person-group> (<year>1979</year>) <article-title>Computer-based system for adverse drug reaction detection and prevention</article-title>. <source>Am J Hospital Pharm</source> <volume>36</volume>: <fpage>198</fpage>–<lpage>201</lpage>.</citation>
</ref>
<ref id="bibr49-2042098613477125">
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Van der Linden</surname><given-names>C.</given-names></name>
<name><surname>Kerskes</surname><given-names>C.</given-names></name>
<name><surname>Bijl</surname><given-names>A.</given-names></name><etal/>
</person-group>. (<year>2006</year>) <article-title>Represcription after adverse drug reaction in the elderly: a descriptive study</article-title>. <source>Arch Intern Med</source> <volume>166</volume>: <fpage>1666</fpage>–<lpage>1667</lpage>.</citation>
</ref>
<ref id="bibr50-2042098613477125">
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Van der Linden</surname><given-names>C.</given-names></name>
<name><surname>Jansen</surname><given-names>P.</given-names></name>
<name><surname>van Geerenstein</surname><given-names>E.</given-names></name><etal/>
</person-group>. (<year>2010</year>) <article-title>Reasons for discontinuation of medication during hospitalization and documentation thereof: a descriptive study of 400 geriatric and internal medicine patients</article-title>. <source>Arch Intern Med</source> <volume>170</volume>: <fpage>1085</fpage>–<lpage>1087</lpage>.</citation>
</ref>
<ref id="bibr51-2042098613477125">
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Van der Sijs</surname><given-names>H.</given-names></name>
<name><surname>Aarts</surname><given-names>J.</given-names></name>
<name><surname>Vulto</surname><given-names>A.</given-names></name><etal/>
</person-group>. (<year>2006</year>) <article-title>Overriding of drug safety alerts in computerized physician order entry</article-title>. <source>J Am Med Informat Assoc</source> <volume>12</volume>: <fpage>138</fpage>–<lpage>147</lpage>.</citation>
</ref>
<ref id="bibr52-2042098613477125">
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Van Doormaal</surname><given-names>J.</given-names></name>
<name><surname>Van den Bemt</surname><given-names>P.</given-names></name>
<name><surname>Zaal</surname><given-names>R.</given-names></name><etal/>
</person-group>. (<year>2009</year>) <article-title>The influence that electronic prescribing has on medication errors and preventable adverse drug events: an interrupted time-series study</article-title>. <source>J Am Med Informat Assoc</source> <volume>16</volume>: <fpage>816</fpage>–<lpage>825</lpage>.</citation>
</ref>
<ref id="bibr53-2042098613477125">
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Varkey</surname><given-names>P.</given-names></name>
<name><surname>Aponte</surname><given-names>P.</given-names></name>
<name><surname>Swanton</surname><given-names>C.</given-names></name><etal/>
</person-group>. (<year>2007</year>) <article-title>The effect of computerized physician-order entry on outpatient prescription errors</article-title>. <source>Managed Care Interface</source> <volume>20</volume>(<issue>3</issue>): <fpage>53</fpage>–<lpage>57</lpage>.</citation>
</ref>
<ref id="bibr54-2042098613477125">
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Weingart</surname><given-names>S.</given-names></name>
<name><surname>Massagli</surname><given-names>M.</given-names></name>
<name><surname>Cyrulik</surname><given-names>A.</given-names></name><etal/>
</person-group>. (<year>2009</year>) <article-title>Assessing the value of electronic prescribing in ambulatory care: a focus group study</article-title>. <source>Int J Med Informat</source> <volume>78</volume>: <fpage>571</fpage>–<lpage>578</lpage>.</citation>
</ref>
<ref id="bibr55-2042098613477125">
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Weingart</surname><given-names>S.</given-names></name>
<name><surname>Toth</surname><given-names>M.</given-names></name>
<name><surname>Sands</surname><given-names>D.</given-names></name><etal/>
</person-group>. (<year>2003</year>) <article-title>Physicians’ decisions to override computerized drug alerts in primary care</article-title>. <source>Arch Intern Med</source> <volume>163</volume>: <fpage>2625</fpage>–<lpage>2631</lpage>.</citation>
</ref>
<ref id="bibr56-2042098613477125">
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Yen</surname><given-names>Y.</given-names></name>
<name><surname>Kuo</surname><given-names>L.</given-names></name>
<name><surname>Hsu</surname><given-names>M.</given-names></name><etal/>
</person-group>. (<year>2010</year>) <article-title>Evaluation of the electronic adverse drug event management system</article-title>. <source>J Exp Clin Med</source> <volume>2</volume>: <fpage>287</fpage>–<lpage>291</lpage>.</citation>
</ref>
<ref id="bibr57-2042098613477125">
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Young</surname><given-names>D.</given-names></name>
</person-group> (<year>2001</year>) <article-title>Electronic system alerts pharmacists to potential adverse drug events</article-title>. <source>Am J Health-Syst Pharm</source> <volume>58</volume>: <fpage>2362</fpage>–<lpage>2365</lpage>.</citation>
</ref>
</ref-list>
</back>
</article>